Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

NMDA receptor antagonists efficacy

Amyotrophic lateral sclerosis is currently treated with riluzole, which improves survival in 30% of patients. Riluzole, an NMDA receptor antagonist, is discussed later in this chapter. A clinical trial of gabapentin, a (y aminobutyric acid (GABA) agonist, in amyotrophic lateral sclerosis demonstrated little efficacy. Antioxidants have also not demonstrated significant efficacy so far. [Pg.674]

See other pages where NMDA receptor antagonists efficacy is mentioned: [Pg.219]    [Pg.222]    [Pg.340]    [Pg.71]    [Pg.696]    [Pg.283]    [Pg.329]    [Pg.697]    [Pg.411]    [Pg.122]    [Pg.83]    [Pg.245]    [Pg.252]    [Pg.253]    [Pg.254]    [Pg.268]    [Pg.646]    [Pg.318]    [Pg.70]    [Pg.284]    [Pg.524]    [Pg.512]    [Pg.512]    [Pg.143]    [Pg.594]    [Pg.11]    [Pg.1070]    [Pg.99]    [Pg.43]    [Pg.1044]    [Pg.72]    [Pg.221]    [Pg.351]    [Pg.359]    [Pg.311]    [Pg.312]    [Pg.313]    [Pg.314]    [Pg.281]    [Pg.108]    [Pg.222]    [Pg.348]    [Pg.367]    [Pg.571]    [Pg.114]    [Pg.228]    [Pg.180]    [Pg.296]    [Pg.109]   
See also in sourсe #XX -- [ Pg.255 ]



SEARCH



NMDA

NMDA antagonists

NMDA receptor antagonists

NMDA receptors

Receptor efficacy

© 2024 chempedia.info